| CAS NO: | 2135632-29-8 |
| 包装 | 价格(元) |
| 1mg | 电议 |
| 5mg | 电议 |
| 生物活性 | Atoltivimab (REGN3470), or maftivimab/odesivimab (Inmazeb) is the first Food and Drug Administration (FDA)-approved monoclonal antibody to target Zaireebolavirus (EBOVs)infection[1]. |
| IC50& Target | Ebolaviru (EBOV)[1] |
| CAS 号 | 2135632-29-8 |
| 储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |
m.cnreagent.com